J&J Cuts 2022 Profit Forecast, Suspends Covid Shot Guidance

4:45am PDT - April 19th, 2022    johnson and johnson vaccine - Bloomberg

Johnson & Johnson cut its annual profit forecast as pharmaceutical sales missed expectations and suspended its guidance for Covid-19 vaccine sales because of unclear demand and global supply surplus.